Addressing Barriers to Palliative Care Use in Bladder Cancer
NCT ID: NCT04598724
Last Updated: 2023-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2020-12-22
2021-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
NCT01846520
Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings
NCT04186884
Community Health Worker Based Intervention to Improve Palliative Care
NCT05407844
Randomized Controlled Trial of Early Palliative Care for Patients With Advanced Cancer
NCT01248624
Early Palliative Care Integration in Interventional Cancer Care
NCT03185416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bladder Cancer Patient Participants
Participants will be scheduled for one-on-one interviews that will occur over Zoom or telephone.
Surveys
Survey will be administered involving questions regarding knowledge and perception of palliative care.
Care Givers for Bladder Cancer Patient Participants
Participants will be scheduled for one-on-one interviews that will occur over Zoom or telephone.
Surveys
Survey will be administered involving questions regarding knowledge and perception of palliative care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surveys
Survey will be administered involving questions regarding knowledge and perception of palliative care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥18 years
* able to speak and read English
* cognitively able to participate in study tasks
* willing to participate in surveys, semi-structured interviews, and/or focus groups
* able to participate in either a Zoom meeting or phone interview
* able to complete an emailed or paper survey
* Patient Participants: a diagnosis of muscle-invasive or locally advanced bladder cancer (stages II-IV).
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
H. Lee Moffitt Cancer Center and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Gilbert, MD
Role: PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Moffitt Cancer Center
Tampa, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCC-20809
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.